INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include INNOVITA. The owner is based in Fengtai District, Beijing.
Floor 1-2, Building 6, Courtyard No.1, Haiying Road,
Fengtai District, Beijing . , CN
Showing of trademarks Trademarks
Trademark Classifications
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. have?
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. file in?
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.'s most well-known trademarks?
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as INNOVITA. These are among 2 currently registered trademarks in the portfolio.
What is INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.'s trademark registration success rate?
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.